Posters & Publications

Date Title View

CIC 2017 <strong>Interim Phase 2 of Indoximod plus Pembrolizumab in Advanced Melanoma</strong>

EHA 2017 <strong>Phase I Indoximod plus Idarubicin &amp; Cytarabine for Newly Diagnosed Acute Myeloid Leukemia</strong>

ASCO 2017 <strong>Phase II Double-blind study of Metastatic Castration-resistant Prostate Cancer</strong>

AACR 2017 <strong>NLG802 Prodrug Poster Presentation</strong>

AACR Plenary 2017 <strong>Indoximod plus Keytruda (pembrolizumab) Phase II Interim in Advanced Melanoma</strong>

SNO 2016 <strong>Indoximod + Temozolomide Brain Tumor Trial</strong>

ASCO 2016 <strong>Pancreas indoximod</strong>

ASCO 2016 <strong>Melanoma indoximod</strong>

ASCO GI 2016 <strong>Indoleamine Phase II Trial</strong>

ASCO GI <strong>Indoximod + Gemcitabine/nab-Paclitaxel</strong>

SABCS 2015 <strong>Indoximod Phase II Metastatic Breast Cancer Trial</strong>

SITC 2015 <strong>GDC-0919 + PD-L1</strong>

ECCO-ESMO 2015 <strong>Indoximod + Ipilimumab Melanoma Trial</strong>

ESMO 2015 <strong>GDC-0919</strong>

ASCO 2015 <strong>Indoximod and Temozolomide</strong>

IUMS <strong>Highly efficacious influenza vaccination using HyperAcute® Technology</strong>

ASCO 2014 <strong>Algenpantucel-L</strong>

ASCO 2014 <strong>Sipuleucel-T +- Indoximod</strong>

ASCO 2014 <strong>Indoximod + Temozolomide</strong>

ASCO 2014 <strong>Tergenpumatucel-L vs. Docetaxel</strong>

ASCO 2014 <strong>Docetaxel + Indoximod</strong>

ASCO 2014 <strong>Ad.p53 + Indoximod</strong>

ASCO 2014 <strong>NLG919</strong>

ASCO 2014 <strong>Indoximod + Ipilimumuab</strong>

ASCO 2014 <strong>Ipilimumab +- Dorgenmeltucel-L</strong>

Ochsner Journal <strong>Combination Immunotherapy for High-Risk Resected ...</strong>

AACR 2014 <strong>IDO + PD1 Synergy</strong>

AACR 2014 <strong>TDO and IDO</strong>

AACR 2013 <strong>NLG919 and Indoximod</strong>

ESMO 2013 <strong>HyperAcute®</strong>

ASCO 2013 <strong>Algenpantucel-L</strong>

BioWorld Today <strong>NewLink's Phase II NSCLC Data Another Immunotherapy Boost</strong>

ASCO 2013 <strong>Ad.p53 DC Indoximod</strong>

ASCO 2013 <strong>Indoximod Docetaxel</strong>

ASCO 2013 <strong>Tergenpumatucel L</strong>